CHRISTOPHER NICHOLS, PH.D.

christopher nichols patent attorney

Counsel
cnichols@mmviplaw.com
Tel. +1 301 453 6100
Fax +1 301 476 4851

Christopher’s practice focuses on representation of biotechnology, pharmaceutical, and chemical companies of all sizes, including the preparation and prosecution of US and foreign patent applications; patentability, infringement, and validity due diligence analyses and opinions. He has legal and technical experience with novel proteins and recombinant DNA; iRNA technology; antibody technology; transgenic animals; gene therapy; bioinformatics; genomics; antimicrobial and cancer therapeutics; imaging and diagnostics, including immunoassays and arrays; plant cell and microbial fermentation methods and equipment; plants; vaccines; and therapeutic biologics. In addition, Christopher has research experience in neuroscience and physiology.

Prior joining the firm, Christopher worked as a NIH Postdoctoral Research Fellow and served as a biotechnology patent examiner in the United States Patent & Trademark Office.

Recognition
  • Randolph Williams Award for outstanding Pro Bono Service, 2010
Publications

“How are Diagnostic Methods Handled by the USPTO” Parts I and II Nichols, Peña, and Posorske Intellectual Property & Technology Law Journal (February and March 2018)

“Marking Your Territory in the Patent World: The Basics of Physical vs. Virtual Patent Marking.” Vivarelli, Nichols, and Hosseini Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2018)

Novartis and Gilead Eviscerate Patent Term Adjustment” Posorske and Nichols Intellectual Property & Technology Law Journal (2016) 28(2)11–15

“Will Patentees Received Patent Term Adjustment After Novartis and Gilead?” Posorske and Nichols Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2015)

“USPTO Begins to Apply Myriad to Pending Patent Applications.” Posorske and Nichols Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2014)

“2012 Eastern District of Virginia Intellectual Property Year in Review.” From Hunton & Williams (2013) Brent Van Normal (editor) and Nichols [contributor]

“New Opportunities for Seeking Patent Term Adjustment Under the AIA.” Posorske and Nichols Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2013)

“Preserving Your Right to Patent Term Adjustment: The Exelixis Decision and Lessons from Wyeth.” Posorske, Nichols, and Vockrodt Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2012)

“‘Micro Entity’ Status Benefits are Limited.” Posorske, Suchyta, and Nichols Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2012)

Merck. v. Integra: Supreme Court Broadly Interprets Safe Harbor Exemption.” Aksman, Messplay, Heisey, and Nichols Client Alert from the Chemical and Biotech Patent Practice at Hunton & Williams (2005)

“Hsp70 dynamics in vivo: effect of heat shock and protein aggregation.”  Zeng, Bhasin, Wu, Lee, Maffi, Nichols, Lee, Taylor, Greene, and Eisenberg Journal of Cell Science (2004) 117: 4991–5000

“Two Invariant Tryptophans on the α1 Subunit Define Domains Necessary for GABAA Receptor Assembly” Srinivasan, Nichols, Lawless, Olsen, and Tobin Journal of Biological Chemistry (1999) 274 (38): 26633–26638

Education
  • George Washington University Law School, JD, 2009
  • UCLA, PhD, Physiology, 2001
  • UCSB, BA, Biology 1995
Bar Admissions
  • California
  • District of Columbia
  • US Patent and Trademark Office
Court Admissions
  • S. District Court for the Central District of California
  • S. District Court for the Southern District of California
  • S. District Court for the Eastern District of California
How can we help you?

Contact us at the MMV IP Law office nearest to you or submit a inquiry online.

x

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.